<--- Back to Details
First PageDocument Content
Pharmaceutics / Pharmaceutical industry / Clinical research / Pharmaceuticals policy / Bioequivalence / Abbreviated New Drug Application / Generic drug / Dissolution testing / Regulatory requirement / Pharmaceutical sciences / Pharmacology / Pharmacokinetics
Date: 2014-12-27 09:48:41
Pharmaceutics
Pharmaceutical industry
Clinical research
Pharmaceuticals policy
Bioequivalence
Abbreviated New Drug Application
Generic drug
Dissolution testing
Regulatory requirement
Pharmaceutical sciences
Pharmacology
Pharmacokinetics

Female Scientific Research Team With Clear Solution In Laboratory

Add to Reading List

Source URL: www.egagenerics.com

Download Document from Source Website

File Size: 699,85 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document